DEADLINE: December 15, 2025 Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: March 10, 2024 to September 29, 2025 Accessibility StatementSkip Navigation LOS ANGELES, Oct. 16, 2025 /PRNewswire/ --Â The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics ("MoonLake " or "the C ...